VJOncology is committed to improving our service to you

Share this video  

VJOncology is committed to improving our service to you

ESMO 2020 | Managing comorbidities in lung cancer patients

Dirk De Ruysscher, MD, PhD, Maastricht University Medical Center, Maastricht, Netherlands outlines the challenges of managing comorbidities and toxicities in lung cancer patients at the ESMO 2020 education weekend. Dr Ruysscher specifically discusses how radiotherapy and chemotherapy contribute to the development of esophagitis, the metabolic impacts esophagitis has in lung cancer patients and how nutrition and exercise management strategies can be integrated into routine clinical care to improve prognosis. This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter